Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

John Abele

Pete M. Nicholas

Boston Scientific Corporation

Fundação Altino Ventura focuses on expanding assistance and establishing partnerships for the professional inclusion of people with disabilities and their caregivers.

Fundação Altino Ventura

Activ Surgical is involved in the development of surgical technologies and tools. Self-described as innovative, it focuses on enhancing surgical procedures through its technological offerings.

Activ Surgical

Med-Tech Innovation Expo is a trade show and exhibition focusing on the medical device manufacturing sector, bringing together professionals from the industry.

Metric
Company Name	Boston Scientific Corporation	Fundação Altino Ventura	Activ Surgical	Med-Tech Innovation Expo
Symbol	BSX
MSH ID	COM:BOSTONSCIENTIFIC	BR:ORG:FUNDACAOALTINOVENTURA	COM:ACTIVSURGICAL	COM:MED-TECHEXPO
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Public & Social Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical - Devices	Non-Profit Organization	Medical Devices	Medical Device Manufacturing
Country	US	BR	US	GB
Stage
Employee Count	48K
Website	bostonscientific.com	fundacaoaltinoventura.org.br	activsurgical.com	med-techexpo.com
LinkedIn				med-tech-innovation
Founders

Metric
Market Cap	113.37B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	14.24B
Revenue (LTM)
Revenue (NTM)
Gross Profit	9.89B
EBITDA	3.62B
Operating Income	2.34B
Net Income	1.59B
EPS	1.08
Diluted EPS	1.07
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.69
Operating Profit Margin	0.18
EBITDA Margin	0.25
Net Profit Margin	0.12
Return on Equity	0.10
Return on Assets	0.05
Return on Capital Employed	0.09

COM:BOSTONSCIENTIFIC

Boston Scientific Corporation

Last Close

91.50

22/11 21:00

Market Cap

113.37B

Beta: -

Volume Today

4.02M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	77.02
P/B Ratio	5.01
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	8.52
EV Multiple	31.41

Metric
Days Sales Outstanding	55.74
Days Payables Outstanding	79.86
Days Inventory Outstanding	207.52
Operating Cycle	264.63
Cash Conversion Cycle	189.09
Asset Turnover	0.42

Metric
Operating Cash Flow	2.50B
Free Cash Flow	1.70B
Cash Flow to Debt	0.26
Operating Cash Flow/Sales	0.18
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	865M
Accounts Receivable	-238M
Inventory	2.48B
Goodwill	14.39B
Debt to Capitalization	0.36
Debt to Assets	0.27
Current Ratio	1.42
Quick Ratio	1.29

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.10
SG&A to Revenue